An interventional study of HMY Model YA-60BB IOL in Aphakia, sponsored by Hoya Surgical Optics, Inc.. Completed at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Hoya Surgical Optics, Inc. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies in Aphakia with a site in United States — 2 open to participants now, 2 under way, none of them phase 3. Aphakia · United States.
Among the 29 studies in Aphakia with a site in United States, this one is the 2nd largest by enrollment of the 23 interventional ones that give a count, is one of 2 that started in 2004, is one of 21 with no phase, and was the 2nd registered.
69 studies on the registry are indexed under Aphakia; 6 are open to participants now.
Browse Aphakia studies →2 of the 29 studies in Aphakia with a site in United States are open now. Recruiting first, the newest first:
Alcon Research · Sites in United States
Ages 22+
Tomey Corporation · Sites in United States
Ages 22+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 6 Aphakia studies recruiting now, 4 set no upper age limit and none stop at 75 or younger; none take children under 18; 1 takes healthy volunteers.
This study: 21 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 3 1 · Phase 4 1
First in 2004; this study’s year is marked. 2 started in 2004.
This study's enrollment of 617 is above the median of 103 across 52 interventional studies indexed under Aphakia.
Median enrollment 155 across the 23 interventional studies, 132 across the 6 observational. Of the 24 that completed or were terminated, 14 (58%) have results posted.
This tab as a report to print or save as PDF → With an account.
27 of 29 have an industry lead sponsor. The 10 most frequent:
Hoya Surgical Optics, Inc. is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Hoya Surgical Optics, Inc. has 4 studies filed under Aphakia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 29 studies in Aphakia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to assess the safety and efficacy of the HMY Model YA-60BB Intraocular Lens (IOL) when implanted in the posterior chamber of the human eye for the optical correction of aphakia following cataract extraction.
A prospective, single-phase, non-randomized, open-label study to include patients with operable cataract of the human crystalline lens who have a potential post-operative best corrected visual acuity of 20/40 or better and no pre-existing progressive sight-threatening ocular disorders. Patients who are eligible per inclusion / exclusion criteria will undergo phacoemulsification cataract extraction and then implantation of the Hoya HMY Model YA-60BB posterior chamber intraocular lens. Each patient will be followed-up at specific time intervals to assess safety and effectiveness, for up to 36 months.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with a history of/or clinical signs of any of the following sight-threatening conditions:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients receiving a Hoya HMY Acrylic Foldable Intraocular Lens.
Device: HMY Model YA-60BB IOL
Following phacoemulsification cataract extraction, insertion of a Hoya HMY posterior chamber intraocular lens will be performed.
Also known as: Hoya HMY Acrylic Foldable Intraocular Lens
Best Corrected Visual Acuity
Time frame: 12 months postoperative
Adverse events/complications
Time frame: 12 months postoperative
The record gives a start of Mar 2004, a primary completion of Dec 2008 and a completion of Dec 2008. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hoya Surgical Optics, Inc.